Keywords
Clinical Conditions
Equipment & Techniques
Science Culture
I study the role of the prefrontal cortex, and associated brain networks, for cognition, behaviour and action. I use both MEG and MRI, together with behavioural, clinical, and neuropsychological data, to investigate healthy adults and patients with neurodegenerative diseases, with a current focus on frontotemporal dementia. My recent research examines the impact of loss of neurotransmission in dementia, especially the neurotransmitters GABA and glutamate, which are the primary inhibitory and excitatory neurotransmitters, as well as serotonin and noradrenaline. Using pharmaco-magnetoencephalography, we investigate the potential for pharmacological enhancement to improve symptoms of disease.
